Bluebell Capital takes stake in pharma giant and puts pressure on Emma WalmsleyGSK’s chief executive, Emma Walmsley, has come under pressure from a second activist hedge fund, Bluebell Capital Partners, which has taken a stake in the drugmaker to push …